Correlation Between IMAC Holdings and Vaxcyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IMAC Holdings and Vaxcyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IMAC Holdings and Vaxcyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between IMAC Holdings and Vaxcyte, you can compare the effects of market volatilities on IMAC Holdings and Vaxcyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IMAC Holdings with a short position of Vaxcyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of IMAC Holdings and Vaxcyte.

Diversification Opportunities for IMAC Holdings and Vaxcyte

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between IMAC and Vaxcyte is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding IMAC Holdings and Vaxcyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxcyte and IMAC Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on IMAC Holdings are associated (or correlated) with Vaxcyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxcyte has no effect on the direction of IMAC Holdings i.e., IMAC Holdings and Vaxcyte go up and down completely randomly.

Pair Corralation between IMAC Holdings and Vaxcyte

Given the investment horizon of 90 days IMAC Holdings is expected to generate 1.37 times more return on investment than Vaxcyte. However, IMAC Holdings is 1.37 times more volatile than Vaxcyte. It trades about -0.14 of its potential returns per unit of risk. Vaxcyte is currently generating about -0.32 per unit of risk. If you would invest  122.00  in IMAC Holdings on August 28, 2024 and sell it today you would lose (15.00) from holding IMAC Holdings or give up 12.3% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

IMAC Holdings  vs.  Vaxcyte

 Performance 
       Timeline  
IMAC Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days IMAC Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Vaxcyte 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Vaxcyte are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Vaxcyte showed solid returns over the last few months and may actually be approaching a breakup point.

IMAC Holdings and Vaxcyte Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IMAC Holdings and Vaxcyte

The main advantage of trading using opposite IMAC Holdings and Vaxcyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IMAC Holdings position performs unexpectedly, Vaxcyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxcyte will offset losses from the drop in Vaxcyte's long position.
The idea behind IMAC Holdings and Vaxcyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Stocks Directory
Find actively traded stocks across global markets